Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
ABM Therapeutics Corporation
ABM Therapeutics Corporation
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
AbbVie
University of South Florida